Press enter to begin your search

ValiRx - Successful Evaluation of Triple Negative Breast Cancer Programme

VAL
Thu, 14 Jul 2022, 13:30 BST

Dr. Suzy Dilly, CEO of ValiRx, discusses the successful evaluation of the company's triple negative breast cancer programme.

Dr Suzanne Dilly
Chief Executive Officer
VAL
62cfdf7f287bf548a3b8d837
SHOW MORE
FROM THIS COMPANY
ValiRx - Successful Evaluation of Triple Negative Breast Cancer Programme
VAL Thu, 14 Jul 2022, 13:30 BST

ValiRx accelerates the development of treatments in cancer and women’s health to improve patient lives. We provide the scientific, financial and commercial framework to enable the rapid translation of innovative science into clinical development.

Industry: Health Care

Contact: +44 (0)2476 796496
Barling Way
https://www.valirx.com/

Dr. Suzy Dilly, CEO of ValiRx, discusses the successful evaluation of the company's triple negative breast cancer programme.

Dr Suzanne Dilly
Chief Executive Officer
POWERED BY